|
ZNF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19850043620329E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85110005102018E-09 |
| Normal-vs-Stage2 |
1.03370000004155E-06 |
| Normal-vs-Stage3 |
1.0184997289997E-10 |
| Normal-vs-Stage4 |
1.42470479858048E-11 |
| Stage1-vs-Stage2 |
4.175600E-01 |
| Stage1-vs-Stage3 |
8.416000E-02 |
| Stage1-vs-Stage4 |
2.345900E-02 |
| Stage2-vs-Stage3 |
7.487800E-02 |
| Stage2-vs-Stage4 |
1.637850E-02 |
| Stage3-vs-Stage4 |
4.290400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68649982867919E-10 |
| Normal-vs-AfricanAmerican |
1.89674999999667E-05 |
| Normal-vs-Asian |
1.82871999999668E-05 |
| Caucasian-vs-AfricanAmerican |
9.275400E-01 |
| Caucasian-vs-Asian |
8.119600E-03 |
| AfricanAmerican-vs-Asian |
1.254650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.73490002761423E-09 |
| Normal-vs-Female |
2.62159960406905E-10 |
| Male-vs-Female |
3.694000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.28239982469347E-10 |
| Normal-vs-Age(41-60Yrs) |
3.47460005212241E-09 |
| Normal-vs-Age(61-80Yrs) |
7.5783002095875E-10 |
| Normal-vs-Age(81-100Yrs) |
3.767100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.337400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.740200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.464800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.394600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.762000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.918900E-03 |
| Classical-VS-Follicular |
7.348600E-01 |
| Classical-VS-Other |
7.697400E-01 |
| Classical-VS-Normal |
7.11049996660051E-09 |
| Tall-VS-Follicular |
2.185500E-02 |
| Tall-VS-Other |
2.762800E-01 |
| Tall-VS-Normal |
2.18409734742409E-11 |
| Follicular-VS-Other |
8.661600E-01 |
| Follicular-VS-Normal |
1.35259999867188E-08 |
| Other-VS-Normal |
9.541700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49959999973248E-08 |
| Normal-vs-N1 |
1.81239467877958E-11 |
| N0-vs-N1 |
8.096700E-03 |
|
|
